High Potency API Contract Manufacturing Market to expand at a 7% value CAGR by 2032 | Says FMI Analyst

The Global High Potency API Contract Manufacturing Market was worth US$ 8 billion in 2022 and is predicted to be worth US$ 16 billion by 2022-2032, at a CAGR of 7%. Because of the increasing incidence of cancer patients worldwide, the use of HPAPIs is increasing, which is boosting the market.

Rising breakthroughs in high potency API (HPAPI) manufacturing technologies, combined with the quest for more effective drugs to improve patient outcomes, have significantly increased the number of HPAPIs in development pipelines, accelerating industry growth. Furthermore, a rising tendency in outsourcing operations due to greater risk management, lower costs, and the availability of modern ways to HPAPI controls has fueled growth.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15786

Key Takeaways from the Market Study

  • FMI projects the global high potency API Contract Manufacturing market to expand at a 7% value CAGR by 2032
  • The global High Potency API Contract Manufacturing market is estimated at a market value of US$ 8 Billion
  • The global high potency API contract manufacturing market is expected to garner a market value of US$ 16 Billion
  • By application, oncology to experience major HPAPI contract manufacturing activities, yielding 63% of global revenue

“Demand for contract manufacturing of HPAPIs has expanded dramatically in recent years, and is one of the primary drivers of the global HPAPI market, owing to a rising number of prospective phase 3 drug candidates.”Says an analyst at FMI

Market Competition

Piramal Pharma Solutions, Lonza, Catalent, Inc., VxP Pharma, Inc., Pfizer CentreOne, Gentec Pharmaceutical Group, AbbVie, Aurigene Pharmaceutical Services Ltd., CordenPharma International and Curia Global, Inc., are some prominent High Potency API Contract Manufacturing manufacturers.

  • In June 2021, Lonza, for example, spent USD 21.5 billion in its Nansha, China, plant to enhance its API development and manufacturing capacity. Three 1,000 L GMP trains totalling 12 cu. ft. of reactor volume m. Additional expenditures will be made, as well as new research and GMP facilities capable of creating small-scale batches of highly effective APIs

Ask For Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15786

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the global automotive axle market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Product Type (Innovative and Generic), Synthesis (Synthetic and Biotech), Application (Oncology, Hormonal Disorders, Glaucoma and Others), Dosage Form (Injectable, Oral Solids, Creams and Others), across five major regions (North America, Latin America, Europe, Asia Pacific, South Asia, East Asia, Oceania and Middle East & Africa).

Key Segments Profiled in the High Potency API Contract Manufacturing Market Industry Survey

High Potency API Contract Manufacturing Market by Product Type:

  • Innovative
  • Generic

High Potency API Contract Manufacturing Market by Synthesis:

  • Synthetic
  • Biotech

High Potency API Contract Manufacturing Market by Application:

  • Oncology
  • Hormonal Disorders
  • Glaucoma
  • Others

High Potency API Contract Manufacturing Market by Dosage Form:

  • Injectable
  • Oral Solids
  • Creams
  • Others

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-15786

More Trending Reports by Future Market Research:

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Leave a comment

Your email address will not be published. Required fields are marked *